AzTrials
AzTrials

Blood DonorsNCT03988738

Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank

A study testing Social Media Publications in people with Blood Donors, run by Universidad Peruana Cayetano Heredia at 1 site in Peru.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Blood donations are an important need worldwide. In Peru, only 10% of donations are voluntary, of which only a quarter are repeat donors. Repeat donations are crucial to maintaining a safe and adequate blood supply. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Blood Donors
What is being tested?
Social Media Publications
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
160 participants
Where
1 sitePeru
Study dates
20 Jun 2019to 24 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Voluntary first-time Blood Donor
  • Eligible to donate blood again
  • Facebook or WhatsApp user

Who cannot join

  • Denial to participate in the study
  • Refusal to be contacted by social media

Trial locations and contacts

1 site in 1 country.

Peru1 site

  • Hospital Nacional Cayetano Heredia Blood Bank

    San Martín de Porres, Lima region, 15102

Other trials in Peru

About this study

Official title: Social Media-based Intervention to Promote Repeat Blood Donation Among First-time Blood Donors in a Peruvian Blood Bank: Randomized Controlled Trial

Blood donations are an important need worldwide. In Peru, only 10% of donations are voluntary, of which only a quarter are repeat donors. Repeat donations are crucial to maintaining a safe and adequate blood supply.

Social media presents a unique opportunity to promote blood donation, because of its increasing use and its prior successes in promoting positive health-related behaviors .

The present study aims to develop and evaluate a social media intervention - Facebook and WhatsApp - to improve communication and promote repeat blood donations in voluntary first-time donors attending donation campaigns organized by the Hospital Nacional Cayetano Heredia (HCH).

Read the detailed description

Main Objective:

To evaluate the effect of social media in the promotion of repeat blood donation among first-time blood donors in a Peruvian blood bank.

Study design:

A randomized control trial will be conducted over a 6-month period, and will compare the rate of repeat blood donation who amongst first-time donors who received promotional messages through social media and those who did not.

Population:

Voluntary first-time blood donors who attend blood donation campaigns organized by the blood bank of the Hospital Nacional Cayetano Heredia (HCH), Lima - Peru.

Sample:

A sample of 105 participants per group was calculated, with a significance of 95% and a power of 80%, to show a difference of 20% in recurrence rate of blood donation between the two groups.

Group assignment:

Participant selection will occur at blood donation campaigns organized by the HCH blood bank. If inclusion and exclusion criteria are met, donors will be invited to participate in the study. After accepting and signing the informed consent form, donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group. All participants will receive an introductory message through social media confirming their participation in the study.

Ethical considerations:

Written informed consent will be requested from participants. Data confidentiality will be maintained. Personal identifiers will be stored in a separate database, which will be password protected and accessible only to the research team.

Conditions
Blood Donors
Being tested
Social Media Publications
Keywords
Blood Donors, Social Media, Blood Donation, Facebook, WhatsApp

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social Media PublicationsOther

    Messages will be elaborated prior to participant enrollment. Messages will be evaluated by three experts.

Study groups in NCT03988738
Study groupRoleWhat they receive
InterventionExperimentalParticipants will receive messages regarding blood donation promotion and campaigns through social media once or twice a week for six months.
Receives: Other: Social Media Publications
ControlSham comparatorParticipants will receive a message regarding blood donation at the beginning of the study through social media. After four months they will receive another message including information about upcoming blood donation campaigns.
Receives: Other: Social Media Publications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Repeat Blood donation rate

    Rate of repeat blood donation will be assessed in both groups after intervention.

    Measured: 6 months

Secondary outcomes (2)

  1. Time interval between blood donations

    Time interval between blood donations will be evaluated in both groups.

    Measured: 6 months

  2. Readiness to Change

    Apply Transtheoretical Model of Change to assess first-time donors´ readiness to change.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2019
  2. Study start20 Jun 2019
  3. Primary completion25 Jan 2020
  4. Study completion24 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03988738
Sponsor's protocol ID
103806
Status last verified
Mar 2020
First submitted
13 Jun 2019
Last updated
11 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • George PE, Vidal J, Garcia PJ. An Analysis of and Recommendations for the Peruvian Blood Collection and Transfusion System. J Epidemiol Public Health Rev. 2016 May;1(3):10.16966/2471-8211.119. doi: 10.16966/2471-8211.119. Epub 2016 Apr 22.

    PubMed 27761524

  • Househ M. The use of social media in healthcare: organizational, clinical, and patient perspectives. Stud Health Technol Inform. 2013;183:244-8.

    PubMed 23388291

  • Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev. 2005 Jan;18(1):12-29. doi: 10.1128/CMR.18.1.12-29.2005.

    PubMed 15653816

  • Hagg E, Dahinten VS, Currie LM. The emerging use of social media for health-related purposes in low and middle-income countries: A scoping review. Int J Med Inform. 2018 Jul;115:92-105. doi: 10.1016/j.ijmedinf.2018.04.010. Epub 2018 Apr 26.

    PubMed 29779724

  • Burditt C, Robbins ML, Paiva A, Velicer WF, Koblin B, Kessler D. Motivation for blood donation among African Americans: developing measures for stage of change, decisional balance, and self-efficacy constructs. J Behav Med. 2009 Oct;32(5):429-42. doi: 10.1007/s10865-009-9214-7. Epub 2009 Apr 14.

    PubMed 19365718

  • Amoyal NR, Robbins ML, Paiva AL, Burditt C, Kessler D, Shaz BH. Measuring the processes of change for increasing blood donation in black adults. Transfusion. 2013 Jun;53(6):1280-90. doi: 10.1111/j.1537-2995.2012.03864.x. Epub 2012 Aug 28.

    PubMed 22928841

  • World Health Organization, International Federation of Red Cross and Red Crescent Societies. Towards 100% voluntary blood donation: A global framework for action [Internet]. Geneva: WHO; 2010 [cited 2019 Jan 29]. Available from: https://www.who.int/bloodsafety/publications/9789241599696_eng.pdf

  • Frye V, Duffy L, France JL, Kessler DA, Rebosa M, Shaz BH, Carlson BW, France CR. The Development of a Social Networking-Based Relatedness Intervention Among Young, First-Time Blood Donors: Pilot Study. JMIR Public Health Surveill. 2018 Apr 26;4(2):e44. doi: 10.2196/publichealth.8972.

    PubMed 29699961

  • Dirección General de Donaciones Trasplantes y Banco de Sangre. Peruvian National Plan for Voluntary Blood Donor Promotion 2018 - 2021 [Internet]. Lima: Peru Ministry of Health; 2018 p. 16. Available from: ftp://ftp2.minsa.gob.pe/normaslegales/2018/Resolucion_Ministerial_672-2018-MINSA.pdf

Questions about this trial

What is this clinical trial studying?

A study testing Social Media Publications in people with Blood Donors, run by Universidad Peruana Cayetano Heredia at 1 site in Peru.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Peru. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Repeat Blood donation rate (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03988738, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2020.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in